Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dorothee Deckbar

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Critical Reviews in Biochemistry and Molecular Biology|April 29, 2011
Understanding the limitations of radiation-induced cell cycle checkpointsDorothee Deckbar, Penny A Jeggo, Markus Löbrich
Cell Cycle (Georgetown, Tex.)|July 20, 2007
An imperfect G2M checkpoint contributes to chromosome instability following irradiation of S and G2 phase cellsAndrea Krempler, Dorothee Deckbar, Penny A Jeggo, et al.
Cancer Research|May 13, 2010
The limitations of the G1-S checkpointDorothee Deckbar, Thomas Stiff, Barbara Koch, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 14, 2011
Elevated radiation-induced γH2AX foci in G2 phase heterozygous BRCA2 fibroblastsAndrea Beucher, Dorothee Deckbar, Eik Schumann, et al.
Molecular Cell|July 29, 2008
ATM signaling facilitates repair of DNA double-strand breaks associated with heterochromatinAaron A Goodarzi, Angela T Noon, Dorothee Deckbar, et al.
The Journal of Cell Biology|March 14, 2007
Chromosome breakage after G2 checkpoint releaseDorothee Deckbar, Julie Birraux, Andrea Krempler, et al.
Molecular and Cellular Biology|April 28, 2010
Role of ATM and the damage response mediator proteins 53BP1 and MDC1 in the maintenance of G(2)/M checkpoint arrestAtsushi Shibata, Olivia Barton, Angela T Noon, et al.
Annals of Hematology|February 11, 2026
Venetoclax and Blinatumomab for adult patients with relapsed/refractory or MRD positive Ph-negative B-cell precursor ALL: phase I part of the GMALL-BLIVEN trialLars Fransecky, Walter Fiedler, Christoph Röllig, et al.
Molecular and Cellular Biology|January 16, 2013
Lamin A/C depletion enhances DNA damage-induced stalled replication fork arrestMayank Singh, Clayton R Hunt, Raj K Pandita, et al.
European Journal of Cancer (Oxford, England : 1990)|June 3, 2026
Papillary renal cell carcinoma - exploratory results of the SUNNIFORECAST trial comparing Ipilimumab plus Nivolumab vs standard of care as first line therapy based on central pathological reviewMarit Ahrens, John Haanen, Laurence Albiges, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Critical Reviews in Biochemistry and Molecular Biology|April 29, 2011
Understanding the limitations of radiation-induced cell cycle checkpointsDorothee Deckbar, Penny A Jeggo, Markus Löbrich
Cell Cycle (Georgetown, Tex.)|July 20, 2007
An imperfect G2M checkpoint contributes to chromosome instability following irradiation of S and G2 phase cellsAndrea Krempler, Dorothee Deckbar, Penny A Jeggo, et al.
Cancer Research|May 13, 2010
The limitations of the G1-S checkpointDorothee Deckbar, Thomas Stiff, Barbara Koch, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 14, 2011
Elevated radiation-induced γH2AX foci in G2 phase heterozygous BRCA2 fibroblastsAndrea Beucher, Dorothee Deckbar, Eik Schumann, et al.
Molecular Cell|July 29, 2008
ATM signaling facilitates repair of DNA double-strand breaks associated with heterochromatinAaron A Goodarzi, Angela T Noon, Dorothee Deckbar, et al.
The Journal of Cell Biology|March 14, 2007
Chromosome breakage after G2 checkpoint releaseDorothee Deckbar, Julie Birraux, Andrea Krempler, et al.
Molecular and Cellular Biology|April 28, 2010
Role of ATM and the damage response mediator proteins 53BP1 and MDC1 in the maintenance of G(2)/M checkpoint arrestAtsushi Shibata, Olivia Barton, Angela T Noon, et al.
Annals of Hematology|February 11, 2026
Venetoclax and Blinatumomab for adult patients with relapsed/refractory or MRD positive Ph-negative B-cell precursor ALL: phase I part of the GMALL-BLIVEN trialLars Fransecky, Walter Fiedler, Christoph Röllig, et al.
Molecular and Cellular Biology|January 16, 2013
Lamin A/C depletion enhances DNA damage-induced stalled replication fork arrestMayank Singh, Clayton R Hunt, Raj K Pandita, et al.
European Journal of Cancer (Oxford, England : 1990)|June 3, 2026
Papillary renal cell carcinoma - exploratory results of the SUNNIFORECAST trial comparing Ipilimumab plus Nivolumab vs standard of care as first line therapy based on central pathological reviewMarit Ahrens, John Haanen, Laurence Albiges, et al.
Pageof 1